PRLD Prelude Therapeutics Inc.

Fundamentals / CIK 0001678660 / USD

Prelude Therapeutics Inc. reported $21.57M in revenue and a net loss of $53.31M for the trailing twelve months ended September 30, 2026 (down 13.1% year over year), with a -283.9% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open PRLD in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

7 fiscal years (2019 to 2025), reported in USD.

$25.39M$12.70M$0-$119.9MFY 2019 Net Income: -$27.57M2019FY 2020 Net Income: -$56.93M2020FY 2021 Net Income: -$111.7M2021FY 2022 Net Income: -$115.4M2022FY 2023 Net Income: -$121.8M2023FY 2024 Revenue: $7.00MFY 2024 Net Income: -$127.2M2024FY 2025 Revenue: $12.14MFY 2025 Net Income: -$99.50M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $12.14M $7.00M -- -- -- -- --
Research & Development $94.30M $118.0M $103.4M $92.89M $86.78M $48.18M $24.28M
Total Operating Expenses $116.7M $146.7M $132.3M $123.5M $113.7M $58.76M $28.11M
Operating Income -$104.6M -$139.7M -$132.3M -$123.5M -$113.7M -$58.76M -$28.11M
EBITDA -$102.9M -$137.9M -$131.1M -$122.2M -$112.8M -$58.22M -$27.73M
Income Tax Expense $0 $0 -- -- -- -- --
Net Income -$99.50M -$127.2M -$121.8M -$115.4M -$111.7M -$56.93M -$27.57M
Basic EPS -$1.29 -$1.68 -$2.02 -$2.44 -$2.43 -$4.56 -$16.52
Diluted EPS -$1.29 -$1.68 -$2.02 -$2.44 -$2.43 -$4.56 -$16.52
Basic Shares Outstanding 77.0M 75.8M 60.4M 47.4M 46.0M 12.5M 1.7M
Diluted Shares Outstanding 77.0M 75.8M 60.4M 47.4M 46.0M 12.5M 1.7M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $5.65M $5.70M $4.58M $5.64M $6.50M $0 $0 --
Research & Development $14.83M $16.13M $13.60M $17.99M $21.71M $25.78M $28.82M $31.62M
Total Operating Expenses $19.91M $21.16M $18.76M $22.99M $26.92M $32.19M $34.61M $37.83M
Operating Income -$14.27M -$15.45M -$14.18M -$17.35M -$20.42M -$32.19M -$34.61M -$33.83M
EBITDA -$13.92M -$15.10M -$13.79M -$16.93M -$19.99M -$31.76M -$34.17M -$33.34M
Net Income -$12.54M -$13.92M -$10.38M -$16.46M -$19.73M -$31.23M -$32.09M -$28.73M
Basic EPS -$0.12 -$0.14 -$0.13 -- -$0.26 -$0.41 -$0.42 --
Diluted EPS -$0.12 -$0.14 -$0.13 -- -$0.26 -$0.41 -$0.42 --
Basic Shares Outstanding 103.1M 98.4M 82.5M -- 76.1M 76.0M 76.0M --
Diluted Shares Outstanding 103.1M 98.4M 82.5M -- 76.1M 76.0M 76.0M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $35.26M $12.47M $25.29M $30.61M $31.83M $218.3M $18.88M
Short-Term Investments $67.96M $121.1M $207.6M $171.1M $259.4M -- --
Cash & Short-Term Investments $103.2M $133.6M $232.9M $201.7M $291.2M $218.3M $18.88M
Total Current Assets $105.7M $135.9M $235.6M $204.4M $295.1M $220.8M $20.22M
Property, Plant & Equipment, Net $5.11M $6.77M $7.33M $4.91M $3.93M $2.48M $1.65M
Total Non-Current Assets $35.62M $39.62M $42.08M $16.12M $9.98M $2.78M $1.65M
Total Assets $141.3M $175.5M $277.7M $220.5M $305.1M $223.6M $21.87M
Accounts Payable $3.98M $7.73M $4.58M $6.78M $7.84M $3.92M $1.97M
Deferred Revenue (Current) $33.73M $0 -- -- -- -- --
Total Current Liabilities $52.99M $25.64M $21.83M $21.70M $19.20M $11.38M $4.83M
Deferred Revenue (Non-Current) $1.80M $0 -- -- -- -- --
Other Non-Current Liabilities $2.84M $3.09M $3.34M $3.36M $0 $32K $5.0K
Total Non-Current Liabilities $19.68M $18.41M $18.75M $3.36M $0 $32K $5.0K
Total Liabilities $72.68M $44.06M $40.58M $25.06M $19.20M $11.41M $4.84M
Total Debt (incl. Leases) $17.79M $18.02M $16.89M $1.83M $1.74M -- --
Retained Earnings -$683.1M -$583.6M -$456.4M -$334.6M -$219.1M -$107.4M -$50.50M
Accumulated Other Comp. Income $8.0K $35K $223K -$1.69M -$711K -- --
Total Stockholders' Equity $68.64M $131.5M $237.1M $195.4M $285.9M $212.2M -$49.41M
Total Equity $68.64M $131.5M $237.1M $195.4M $285.9M $212.2M -$49.41M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $23.41M $26.33M $21.76M $35.26M $47.53M $25.75M $40.27M $12.47M
Short-Term Investments $116.6M $125.4M $59.80M $67.96M $7.42M $47.46M $58.80M $121.1M
Cash & Short-Term Investments $140.0M $151.8M $81.55M $103.2M $54.96M $73.22M $99.07M $133.6M
Total Current Assets $142.4M $154.9M $84.59M $105.7M $58.33M $76.88M $102.4M $135.9M
Property, Plant & Equipment, Net $4.06M $4.40M $4.72M $5.11M $5.53M $5.96M $6.39M $6.77M
Total Non-Current Assets $33.06M $34.47M $35.05M $35.62M $36.42M $38.04M $38.86M $39.62M
Total Assets $175.5M $189.4M $119.6M $141.3M $94.75M $114.9M $141.3M $175.5M
Accounts Payable $2.97M $2.03M $2.07M $3.98M $2.53M $4.96M $5.83M $7.73M
Deferred Revenue (Current) $19.60M $25.25M $30.95M $33.73M -- -- -- $0
Total Current Liabilities $33.93M $38.04M $41.72M $52.99M $18.19M $20.91M $19.79M $25.64M
Deferred Revenue (Non-Current) $0 $0 $0 $1.80M -- -- -- $0
Other Non-Current Liabilities $2.65M $2.72M $2.78M $2.84M $2.90M $2.97M $3.03M $3.09M
Total Non-Current Liabilities $17.42M $17.59M $17.74M $19.68M $18.03M $18.17M $18.30M $18.41M
Total Liabilities $51.35M $55.63M $59.46M $72.68M $36.22M $39.08M $38.08M $44.06M
Total Debt (incl. Leases) $17.56M $17.65M $17.72M $17.79M $17.85M $17.92M $17.92M $18.02M
Retained Earnings -$719.9M -$707.4M -$693.4M -$683.1M -$666.6M -$646.9M -$615.6M -$583.6M
Accumulated Other Comp. Income -$533K -$227K -$41K $8.0K $2.0K -$1.0K $12K $35K
Total Stockholders' Equity $124.1M $133.7M $60.18M $68.64M $58.53M $75.84M $103.2M $131.5M
Total Equity $124.1M $133.7M $60.18M $68.64M $58.53M $75.84M $103.2M $131.5M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$99.50M -$127.2M -$121.8M -$115.4M -$111.7M -$56.93M -$27.57M
Depreciation & Amortization $1.71M $1.77M $1.17M $1.32M $915K $542K $382K
Stock-Based Compensation $11.91M $21.34M $25.62M $25.14M $20.93M $5.58M $846K
Change in Payables -$3.92M $3.31M -$2.27M -$347K $3.90M $1.16M $546K
Operating Cash Flow -$56.30M -$102.9M -$107.1M -$83.73M -$83.53M -$46.18M -$25.66M
Capital Expenditure -$67K -$764K -$3.51M -$3.02M -$2.32M -$621K -$780K
Free Cash Flow -$56.37M -$103.7M -$110.6M -$86.75M -$85.85M -$46.80M -$26.45M
Purchases of Investments -$100.9M -$52.69M -$221.6M -$119.2M -$261.5M -- --
Investing Cash Flow $53.46M $90.19M -$34.65M $81.69M -$263.8M -$621K -$780K
Common Stock Issued -- -- -- -- $161.4M -- --
Financing Cash Flow $24.82M -$120K $136.4M $815K $164.9M $246.2M $29.73M
Net Change in Cash $21.97M -$12.82M -$5.31M -$1.22M -$182.4M $199.4M $3.28M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$12.54M -$13.92M -$10.38M -$16.46M -$19.73M -$31.23M -$32.09M -$28.73M
Depreciation & Amortization $341K $353K $391K $418K $425K $433K $435K $489K
Stock-Based Compensation $2.03M $2.03M $2.00M $1.84M $2.42M $3.81M $3.83M $3.77M
Change in Payables $1.02M -$154K -$1.88M $1.27M -$2.43M -$850K -$1.91M $1.81M
Operating Cash Flow -$13.78M -$15.57M -$21.68M $23.12M -$19.11M -$26.07M -$34.23M -$20.74M
Capital Expenditure -$35K $0 $0 $0 $0 -$20K -$47K -$53K
Free Cash Flow -$13.81M -$15.57M -$21.68M $23.12M -$19.11M -$26.09M -$34.28M -$20.80M
Purchases of Investments -$6.72M -$89.97M $0 -$66.74M $0 -$24.66M -$9.46M -$7.33M
Investing Cash Flow $9.02M -$65.50M $8.50M -$60.34M $40.09M $11.52M $62.19M $22.12M
Financing Cash Flow $1.17M $85.82M -$314K $24.94M -$5.0K $37K -$160K -$34K
Net Change in Cash -$3.60M $4.74M -$13.50M -$12.28M $20.97M -$14.52M $27.80M $1.34M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -861.3% -1995.9% -- -- -- -- --
Net Profit Margin -819.6% -1816.8% -- -- -- -- --
Return on Equity (ROE) -145.0% -96.7% -51.4% -59.1% -39.1% -26.8% --
Return on Assets (ROA) -70.4% -72.5% -43.9% -52.4% -36.6% -25.5% -126.1%
Current Ratio 1.99x 5.30x 10.79x 9.42x 15.37x 19.41x 4.18x
Quick Ratio 1.95x 5.21x 10.67x 9.30x 15.17x 19.19x 3.90x
Debt to Equity 0.26x 0.14x 0.07x 0.01x 0.01x -- --
Revenue Growth (YoY) +73.4% -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -283.9% -300.6% -503.2% -861.3% -- -- -- --
Net Profit Margin -247.1% -269.7% -465.3% -819.6% -- -- -- --
Return on Equity (ROE) -42.9% -45.2% -129.3% -145.0% -191.0% -163.9% -123.9% -96.7%
Return on Assets (ROA) -30.4% -31.9% -65.0% -70.4% -118.0% -108.2% -90.5% -72.5%
Current Ratio 4.20x 4.07x 2.03x 1.99x 3.21x 3.68x 5.18x 5.30x
Quick Ratio 4.13x 3.99x 1.95x 1.95x 3.02x 3.50x 5.01x 5.21x
Debt to Equity 0.14x 0.13x 0.29x 0.26x 0.31x 0.24x 0.17x 0.14x
Revenue Growth (YoY) -13.1% -- -- -- +116.7% -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001678660) · from March 31, 2019 Data through September 30, 2026 · synced Nov 20, 2026, 05:43 UTC · Open in terminal